novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Nuclear magnetic resonance in patients with implanted devices

13 Julho 2012

Johannes Sperzel

RESUMO DA APRESENTAÇÃO

Chronic ischemic heart disease, a forgotten entity?

13 Julho 2012
0

Left atrial appendage closure. A new opportunity to prevent stroke

13 Julho 2012
0

-->